Researchers are redefining the nutritional value of prey. Studying the dynamics of sea lion predators and their prey, the researchers found that not all prey are the same — even those of similar size and […]
For the first time in 66 years, the principles of modern-day weather forecasting will be used to enhance a Northern California reservoir’s dual mission of flood risk management and water supply security. Click here to […]
Novartis said it is acquiring Avidity Biosciences for approximately $12 billion, the companies said Sunday, in a deal designed to bolster the buyer’s neuroscience pipeline with three late-stage programs. Headquartered in San Diego, Avidity is […]
Innovative telehealth startup introduces inhalable ED and migraine relief plus a gut-friendly metformin gummy for blood sugar and longevity SAN DIEGO, Oct. 27, 2025 /PRNewswire/ — ForHumanity Health Inc. today announced its public launch, introducing […]
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Oct. 27, 2025 (GLOBE NEWSWIRE) — ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, presented posters […]
CARLSBAD, Calif.–(BUSINESS WIRE)–Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that detailed data from the landmark pivotal Phase 3 CORE and CORE2 studies of olezarsen in people with severe hypertriglyceridemia (sHTG) will be presented during a […]
UC San Diego researchers have settled a decades-long debate surrounding the role of the first Crohn’s disease gene to be associated with a heightened risk for developing the auto-immune condition. Click here to view original […]
Almost a year after buying Kate Therapeutics, Novartis has scooped up another San Diego-based muscle dystrophy biotech in one of the biggest acquisitions of 2025 so far. Click here to view original post Click Here […]
We are gearing up for our annual AI in Drug Discovery summit in a few days. So, for this episode, we focused on some recent AI news coverage. First, GEN senior editor Fay Lin, PhD, […]
Researchers have discovered a way to make yeast cells more efficient “factories” for sustainably producing valuable plant compounds, which could be used to help plants defend against disease, repel pests, attract pollinators, and withstand environmental […]
LA JOLLA—The rate of HIV infection continues to climb globally. Around 40 million people live with HIV-1, the most common HIV strain. While symptoms can now be better managed with lifelong treatment, there is no […]
SAN DIEGO, Oct. 24, 2025 /PRNewswire/ — ChemDiv, a global provider of integrated drug discovery solutions, today announced that it will continue providing chemistry, computational, and clinical pharmacology support to Clywedog Therapeutics as the company […]
SAN DIEGO, Oct. 24, 2025 /PRNewswire/ — ChemDiv today announced the extension of its discovery and early development partnership with Mondego Bio to advance the company’s best-in-class immuno-oncology program targeting PTPN2. The announcement follows Mondego […]
Inhibrx Biosciences’ antibody ozekibart has notched a key phase 2 win in a rare bone cancer that currently has no approved treatments, prompting the San Diego biotech to plot a submission to the FDA in […]
Copyright © 2026 Biotech Networks, LLC
